Institute for Complex Engineered Systems: A Fireside Chat
- Hamburg Hall
- CHRISTIAN MACEDONIA
- Managing Partner , Lancaster Maternal Fetal Medicine, and
- CEO, Lancaster Maternal Fetal Medicine
- Adjunct Associate Professor, Department of Department of Gynecology and Obstetrics, School of Medicine, Johns Hopkins University
The Need for Innovative Science to Create a Diagnostic Hive for Better Outcomes
Please join us for a Fireside Chat with Dr. Christian Macedonia, Lancaster Maternal Fetal Medicine, and Dr. Alan Russell, CMU Highmark Distinguished Career Professor & Director of the Disruptive Health Technology Institute, for a candid discussion about the problems afflicting American Healthcare and the ways that research scientists can collaborate with clinicians to solve big problems.
Dr. Macedonia believes that all Americans should have equal access to advanced healthcare technologies no matter where they live and that these technologies can be specifically designed to lower healthcare costs, improve quality, increase accessibility, and enhance the relationships between providers and patients.
He believes that a diagnostic hive could be a way of decreasing costs and improving quality by breaking diagnostic problems into individual parts, distributing the problem to a group of diagnosticians and AI platform, that can rapidly produce results available to primary providers anywhere on the planet. He also believes that this form of distributed intelligence can work with surgical or interventional tasks as well, through tele-robotics.
He believes that researchers at CMU are the perfect partners to help make this a reality.
Christian Macedonia MD is a Managing Partner at Lancaster Maternal Fetal Medicine and CEO of Lancaster Life Sciences Group, a small tech startup in Lancaster PA. He is an Adjunct Associate Professor of Gynecology and Obstetrics at the Johns Hopkins University School of Medicine. Prior to entering the private sector, Dr. Macedonia spent three decades serving in a variety of roles including as a multiply deployed combat surgeon in hot-spots around the globe. He performed pioneering work at the NIH and Walter Reed in the creation of the first bedside 3D ultrasound machine under a DARPA grant and finished his career as a DoD senior executive and DARPA program manager. His last military assignment was as the Medical Sciences Adviser to the Chairman of the Joint Chiefs of Staff where he commanded the DoD “Gray Team” reforming TBI and Post Traumatic Stress care in the combat zones and in the US. Along with his healthcare, science, and technology interests, Dr. Macedonia has pursued exploration including work as a climb doctor on Everest, a 2000 archaeology dive to the RMS Titanic, and exploring remote regions of the Amazon River along with humanitarian aid efforts in other far-flung regions. He and his wife live on a small farm in Lancaster tending to myotonic (fainting) goats.
Dr. Alan Russell (Ph.D. in Biological Chemistry, 1987, Imperial College of Science and Technology, University of London) is the Highmark Distinguished Career Professor at Carnegie Mellon University where he directs the Disruptive Health Technology Institute. From 2012-2016 Dr. Russell served as the Executive Vice President and the Chief Innovation Officer of the Allegheny Health Network and Highmark Health. He was the Founding Director of the McGowan Institute for Regenerative Medicine at the University of Pittsburgh, serving in that capacity from 2001-2011. Dr. Russell has founded three biotechnology companies (including one that became a successful public company) and was also the Founding President of the Tissue Engineering and Regenerative Medicine International Society.
Dr. Russell was the longest serving member of the Science Board to the Food and Drug Administration and Chaired the 10-year scientific review of the Center for Devices and Radiologic Health, publishing the key “Protecting the core of CDRH regulatory science in the face of financial and strategic threats” report. Dr. Russell has served many scientific roles for the Department of Defense, including being a member of the Defense Health Board. For the last 25 years, the Russell laboratory has been discovering what can be achieved by exploiting the rich interface of chemistry, biology and materials. Dr. Russell’s work has impacted fields as diverse as chemical and polymer synthesis to tissue engineering and homeland defense.